Skip to main content
. 2016 Sep 2;7(43):70185–70193. doi: 10.18632/oncotarget.11824

Figure 2. Forest plots of hazard ratios for 2-year, 3-year and 5-year OS in patients between weekly and three weekly cisplatin chemoradiotherapy.

Figure 2

OS=overall survival. CI=confidence interval, I2=index of heterogeneity.